These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20198479)

  • 21. The role of amyloid beta peptide 42 in Alzheimer's disease.
    Findeis MA
    Pharmacol Ther; 2007 Nov; 116(2):266-86. PubMed ID: 17716740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraneuronal Abeta42 accumulation in Down syndrome brain.
    Mori C; Spooner ET; Wisniewsk KE; Wisniewski TM; Yamaguch H; Saido TC; Tolan DR; Selkoe DJ; Lemere CA
    Amyloid; 2002 Jun; 9(2):88-102. PubMed ID: 12440481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production.
    Valerio A; Boroni F; Benarese M; Sarnico I; Ghisi V; Bresciani LG; Ferrario M; Borsani G; Spano P; Pizzi M
    Eur J Neurosci; 2006 Apr; 23(7):1711-20. PubMed ID: 16623827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abeta peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons.
    Clifford PM; Zarrabi S; Siu G; Kinsler KJ; Kosciuk MC; Venkataraman V; D'Andrea MR; Dinsmore S; Nagele RG
    Brain Res; 2007 Apr; 1142():223-36. PubMed ID: 17306234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative paucity of tau accumulation in the small areas with abundant Abeta42-positive capillary amyloid angiopathy within a given cortical region in the brain of patients with Alzheimer pathology.
    Oshima K; Akiyama H; Tsuchiya K; Kondo H; Haga C; Shimomura Y; Iseki E; Uchikado H; Kato M; Niizato K; Arai H
    Acta Neuropathol; 2006 Jun; 111(6):510-8. PubMed ID: 16718347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid and Tau accumulate in the brains of aged hydrocephalic rats.
    Silverberg GD; Miller MC; Machan JT; Johanson CE; Caralopoulos IN; Pascale CL; Heile A; Klinge PM
    Brain Res; 2010 Mar; 1317():286-96. PubMed ID: 20045398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42/Abeta40 ratio and total tau.
    Lewczuk P; Esselmann H; Otto M; Maler JM; Henkel AW; Henkel MK; Eikenberg O; Antz C; Krause WR; Reulbach U; Kornhuber J; Wiltfang J
    Neurobiol Aging; 2004 Mar; 25(3):273-81. PubMed ID: 15123331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oligomerization partially explains the lowering of Abeta42 in Alzheimer's disease cerebrospinal fluid.
    Englund H; Degerman Gunnarsson M; Brundin RM; Hedlund M; Kilander L; Lannfelt L; Pettersson FE
    Neurodegener Dis; 2009; 6(4):139-47. PubMed ID: 19521063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: predominance of Abeta42(43).
    Mann DM; Iwatsubo T; Cairns NJ; Lantos PL; Nochlin D; Sumi SM; Bird TD; Poorkaj P; Hardy J; Hutton M; Prihar G; Crook R; Rossor MN; Haltia M
    Ann Neurol; 1996 Aug; 40(2):149-56. PubMed ID: 8773595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adhesion molecule L1 binds to amyloid beta and reduces Alzheimer's disease pathology in mice.
    Djogo N; Jakovcevski I; Müller C; Lee HJ; Xu JC; Jakovcevski M; Kügler S; Loers G; Schachner M
    Neurobiol Dis; 2013 Aug; 56():104-15. PubMed ID: 23639788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebellar diffuse amyloid plaques are derived from dendritic Abeta42 accumulations in Purkinje cells.
    Wang HY; D'Andrea MR; Nagele RG
    Neurobiol Aging; 2002; 23(2):213-23. PubMed ID: 11804705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial DNA copy numbers in pyramidal neurons are decreased and mitochondrial biogenesis transcriptome signaling is disrupted in Alzheimer's disease hippocampi.
    Rice AC; Keeney PM; Algarzae NK; Ladd AC; Thomas RR; Bennett JP
    J Alzheimers Dis; 2014; 40(2):319-30. PubMed ID: 24448779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel approach for Aβ₁₋₄₀ quantification using immuno-PCR.
    Hashimoto M; Aoki M; Winblad B; Tjernberg LO
    J Neurosci Methods; 2012 Apr; 205(2):364-7. PubMed ID: 22327103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum amyloid beta protein in young and elderly depression: a pilot study.
    Kita Y; Baba H; Maeshima H; Nakano Y; Suzuki T; Arai H
    Psychogeriatrics; 2009 Dec; 9(4):180-5. PubMed ID: 20377819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wild-type, Flemish, and Dutch amyloid-β exhibit different cytotoxicities depending on Aβ40 to Aβ42 interaction time and concentration ratio.
    Shahnawaz M; Sharoar MG; Shin SY; Park IS
    J Pept Sci; 2013 Sep; 19(9):545-53. PubMed ID: 23853087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons.
    D'Andrea MR; Nagele RG
    Curr Pharm Des; 2006; 12(6):677-84. PubMed ID: 16472157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consistent immunohistochemical detection of intracellular beta-amyloid42 in pyramidal neurons of Alzheimer's disease entorhinal cortex.
    D'Andrea MR; Nagele RG; Wang HY; Lee DH
    Neurosci Lett; 2002 Nov; 333(3):163-6. PubMed ID: 12429373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential Effects of Alzheimer's Disease Aβ40 and 42 on Endocytosis and Intraneuronal Trafficking.
    Omtri RS; Thompson KJ; Tang X; Gali CC; Panzenboeck U; Davidson MW; Kalari KR; Kandimalla KK
    Neuroscience; 2018 Mar; 373():159-168. PubMed ID: 29337241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in the cellular uptake and intracellular itineraries of amyloid beta proteins 40 and 42: ramifications for the Alzheimer's drug discovery.
    Omtri RS; Davidson MW; Arumugam B; Poduslo JF; Kandimalla KK
    Mol Pharm; 2012 Jul; 9(7):1887-97. PubMed ID: 22574751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo.
    Fassbender K; Simons M; Bergmann C; Stroick M; Lutjohann D; Keller P; Runz H; Kuhl S; Bertsch T; von Bergmann K; Hennerici M; Beyreuther K; Hartmann T
    Proc Natl Acad Sci U S A; 2001 May; 98(10):5856-61. PubMed ID: 11296263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.